|
|
|
|
|
|
|
Fig. 3
GG211 (topoisomerase I inhibitor) area under the blood lactone concentration on day 4 of dosing
versus absolute neutrophil nadir and platelet nadir in cancer patients from San Antonio and Rotterdam.
The data were fit to both a sigmoidal Emax and a linear regression model. |
|
|
|
|
|
